| 12.58 -0.43 (-3.31%) | 03-05 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 15.8 | 1-year : | 16.91 |
| Resists | First : | 13.53 | Second : | 14.47 |
| Pivot price | 13.35  |
|||
| Supports | First : | 12 | Second : | 9.98 |
| MAs | MA(5) : | 12.95 |
MA(20) : | 13.49 |
| MA(100) : | 12.48  |
MA(250) : | 10.73 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 29.3 |
D(3) : | 37.9 |
| RSI | RSI(14): 34.7 |
|||
| 52-week | High : | 14.56 | Low : | 6.76 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ VREX ] has closed below the lower bollinger band by 9.1%. If price is in a downtrend band; this downward trend might continue. However a short term pullback inside the band is likely. Bollinger Bands are 11.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 12.96 - 13.03 | 13.03 - 13.09 |
| Low: | 12.15 - 12.25 | 12.25 - 12.33 |
| Close: | 12.43 - 12.58 | 12.58 - 12.7 |
Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, 3D reconstruction and computer-aided diagnostic software, collimators, automatic exposure control devices, generators, heat exchangers, ionization chambers, and buckys. This segment's products are used in a range of applications, including radiographic and fluoroscopic imaging, mammography, computed tomography, radiation therapy, oncology, CT, cardiac, surgery, dental, computer-aided detection, and other diagnostic radiography uses. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital detectors, and high voltage connectors for use in security and industrial inspection applications, such as airport security, cargo screening at ports and borders, and nondestructive testing and examination in various applications. Varex Imaging Corporation sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was founded in 2016 and is based in Salt Lake City, Utah.
Wed, 04 Mar 2026
VREX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Sun, 01 Mar 2026
Varex Imaging (NASDAQ:VREX) Short Interest Update - MarketBeat
Fri, 27 Feb 2026
(VREX) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Thu, 26 Feb 2026
Varex Imaging Corporation (VREX) Stock Analysis: Navigating A 34.9% Upside Potential - DirectorsTalk Interviews
Thu, 19 Feb 2026
Varex Imaging Corporation (VREX) Stock Analysis: Exploring A 33% Upside Potential - DirectorsTalk Interviews
Fri, 13 Feb 2026
Director at Varex Imaging (VREX) awarded 14,947 deferred stock units - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 42 (M) |
| Shares Float | 41 (M) |
| Held by Insiders | 1.5 (%) |
| Held by Institutions | 98.8 (%) |
| Shares Short | 812 (K) |
| Shares Short P.Month | 843 (K) |
| EPS | -1.64 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 11.38 |
| Profit Margin | -8 % |
| Operating Margin | 7.3 % |
| Return on Assets (ttm) | 3.6 % |
| Return on Equity (ttm) | -12.9 % |
| Qtrly Rev. Growth | 4.9 % |
| Gross Profit (p.s.) | 6.96 |
| Sales Per Share | 20.38 |
| EBITDA (p.s.) | 2.31 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 16 (M) |
| Levered Free Cash Flow | -16 (M) |
| PE Ratio | -7.68 |
| PEG Ratio | 0 |
| Price to Book value | 1.1 |
| Price to Sales | 0.61 |
| Price to Cash Flow | 32.75 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|